USA Non Profit Gastroenterology Research Institute
LABORATORIES DIHDC® (Delaware Institute of Hepatitis and Digestive Cancers, Inc.) is an USA Non - Profit Hepato-Gastroenterology Research Institute with United States Patent and Trademark Registration under number #8332134 Headquartered in Delaware, Wilmington, specialized in Clinical Research, Development and manufacturing Hepatectomy materials devices, Antivirals Drugs, Anticancers Drugs, HBV Vaccines, Hepatoprotectors Drugs, HBV DNA, HCV RNA, Cancers Gene Mutations, Cancer Vaccines, CAR T - Cell Therapy, Immune Chekpoint Inhibitors, Cytokines, Monoclonal Antibodies, ERCP(Endoscopic Retrograde Cholangiopancreatography, EUS(Endoscopic Ultrasound), ESD/EMR (Endoscopic Submucosal Dissection/Resection), Stenting/Dilation, Per - Oral Endoscopic Myotomy (POEM), Ablation Therapies, EDGE Procedure (EUS - directec transgastric - ERCP), Zenker's Diverticulotomy, Necrosectomy and EUS - guided Gastroenterology, Transarterial Chemoembolization, Transarterial Radioembolization, Radiofrequency Ablation, Cryoablation, Microwave Ablation... for the treatment of Chronic Hepatitis B/C/A/D/E, Liver Cirrhosis, Hepatocellular and Gastrointestinal Cancers, and Inflammatory Bowels Diseases.
LABORATORIES DIHDC® is also a Hepato-Gastroenterology Research Institute with five USA Licenses provided by State of Delaware Division of Revenue (General Service Licence #2026706430, Manufacturer License #2026706432, Pharmaceutical Distribution Wholesaler License #2026706431, Sales Representative License #2026706433 and Trade Name only Business Registration #2026708299).
LABORATORIES DIHDC® provides advanced care and clinical trials for the people living with Chronic Liver Diseases, Digestive cancers, Diabetes and Inflammatory Bowels Diseases.
LABORATORIES DIHDC® performs international seminars and training in hepatitis treatment, immunotherapies, locoregional therapies, interventional endoscopies, immuno-cancerology, ....